| name | endo-against-plasmapheresis-tg-pancreatitis |
| description | This skill recommends against using acute plasmapheresis as first-line therapy to lower triglycerides in triglyceride-induced pancreatitis. Trigger phrases include "Patient presents with triglyceride-induced pancreatitis" and "Considering plasmapheresis for acute pancreatitis management". |
Avoid acute plasmapheresis for triglyceride-induced pancreatitis
STEP 1 — Gather Information
Record triglyceride level, assess for pancreatitis symptoms (epigastric pain, nausea/vomiting), check serum lipase ≥3× ULN, exclude gallstones (right upper quadrant ultrasound) and alcohol use, and document pregnancy status.
STEP 2 — Rule In / Rule Out
If triglycerides >500 mg/dL and pancreatitis confirmed with no gallstone/alcohol cause, proceed to classify TG-induced pancreatitis; otherwise, consider alternative diagnoses and manage accordingly.
STEP 3 — Classify or Stratify
If triglycerides <10,000 mg/dL and patient is not pregnant, classify as standard TG-induced pancreatitis; if triglycerides ≥10,000 mg/dL or patient is pregnant, classify as high-risk/extraordinary TG elevation.
STEP 4 — Decide
For standard TG-induced pancreatitis, advise against acute plasmapheresis and initiate conservative management (NPO, low-fat diet, glycemic control with insulin if hyperglycemic); for high-risk/extraordinary TG elevation, consider plasmapheresis only after failure of conventional TG-lowering measures (fibrates, omega-3 fatty acids, very low-fat diet).
Clinical Guardrails / Mimics / Pitfalls
Do not use plasmapheresis as first-line therapy; avoid delaying standard care (NPO, low-fat diet, glycemic control); monitor for thrombocytopenia and bleeding complications; do not rely on plasmapheresis to address underlying hypertriglyceridemia etiology.
Concrete Clinical Example
A 45‑year‑old woman presents with epigastric pain, lipase 4× ULN, triglycerides 850 mg/dL, negative gallstone ultrasound, no alcohol use, and not pregnant. She is diagnosed with triglyceride‑induced pancreatitis. Per guideline, acute plasmapheresis is avoided; she is kept NPO, started on insulin infusion for hyperglycemia, and later prescribed fenofibrate after discharge.
Source: Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2020, doi:10.1210/clinem/dgaa674
